Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease
Summary
- Diagnostic criteria for glucose disorders in HIV-infected patients on ART have been described (Table 9)[ADA 2013a; ADA 2013b]
- Fasting, random, or oral glucose tolerance testing may be used in screening patients
- Fasting blood glucose should be undertaken in all HIV-infected patients at entry to care, every 6-12 months thereafter, and before ART initiation
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content